CoChat

Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study

Open access
Brownrigg, Jack R W, Hughes, Cian O, Burleigh, David, Karthikesalingam, Alan, Patterson, Benjamin O, Holt, Peter J, Thompson, Matthew M, de Lusignan, Simon, Ray, Kausik K, Hinchliffe, Robert J · 2016 · The Lancet Diabetes & Endocrinology

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Background Diabetes confers a two times excess risk of cardiovascular disease, yet predicting individual risk remains challenging. The effect of total microvascular disease burden on cardiovascular disease risk among individuals with diabetes is unknown.Methods A population-based cohort of patients with type 2 diabetes from the UK Clinical Practice Research Datalink was studied (n=49 027). We used multivariable Cox models to estimate hazard ratios (HRs) for the primary outcome (the time to first major cardiovascular event, which was a composite of cardiovascular death, non-fatal myocardial infarction, or non-fatal ischaemic stroke) associated with cumulative burden of retinopathy, nephropathy, and peripheral neuropathy among individuals with no history of cardiovascular disease at baseline.Findings During a median follow-up of 5·5 years, 2822 (5·8%) individuals experienced a primary outcome. After adjustment for established risk factors, significant associations were observed for the primary outcome individually for retinopathy (HR 1·39, 95% CI 1·09-1·76), peripheral neuropathy (1·40, 1·19-1·66), and nephropathy (1·35, 1·15-1·58). For individuals with one, two, or three microvascular disease states versus none, the multivariable-adjusted HRs for the primary outcome were 1·32 (95% CI 1·16-1·50), 1·62 (1·42-1·85), and 1·99 (1·70-2·34), respectively. For the primary outcome, measures of risk discrimination showed significant improvement when microvascular disease burden was added to models. In the overall cohort, the net reclassification index for USA and UK guideline risk strata were 0·036 (95% CI 0·017-0·055, p<0·0001) and 0·038 (0·013-0·060, p<0·0001), respectively.Interpretation The cumulative burden of microvascular disease significantly affects the risk of future cardiovascular disease among individuals with type 2 diabetes. Given the prevalence of diabetes globally, further work to understand the mechanisms behind this association and strategies to mitigate this excess risk are warranted.Funding Circulation Foundation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(16)30057-2

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 272

Metadata

Authors
Brownrigg, J. R. W., Hughes, C. O., Burleigh, D., Karthikesalingam, A., Patterson, B. O., Holt, P. J., Thompson, M. M., de Lusignan, S., Ray, K. K., & Hinchliffe, R. J.
Affiliations
  • St George's, University of London (GB)
  • University of Surrey (GB)
  • Imperial College London (GB)
  • University of Bristol (GB)
Corresponding author
Brownrigg, Jack R W
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2016-07
Volume
4
Issue
7
Pages
588-597
ISSN
2213-8587 (ISSN-L)
OpenAlex
W2405585158
Cited by
242
References
39
Citations by year
2026: 13 · 2025: 21 · 2024: 29 · 2023: 21 · 2022: 30 · 2021: 30 · 2020: 31 · 2019: 26 · 2018: 21 · 2017: 13 · 2016: 6
FWCI
22.09
Type
journal article
Language
en
Licence
  • cc-by-nc-nd
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Diabetes & Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • St George's Online Research Archive (St George's University of London) (acceptedVersion)
  • Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
  • Explore Bristol Research (submittedVersion, cc-by-nc-nd)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
Funders
  • National Institute for Health and Care Research (NF-SI-0514-10114, CL-2007-16-002, NIHR-CS-011-008)
  • British Heart Foundation (PG/13/98/30490)
  • Circulation Foundation
  • Medical Research Council (MR/K025643/1)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, microangiopathy, cardiovascular risk, retinopathy, diabetic nephropathy, peripheral neuropathy, major adverse cardiovascular events, cardiovascular mortality, myocardial infarction, ischemic stroke, risk prediction, net reclassification improvement, risk discrimination, Clinical Practice Research Datalink, primary prevention of cardiovascular disease
MeSH terms
Aged, Aged, 80 and over, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, United Kingdom, Heart Failure, Humans, Male, Middle Aged, Cohort Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. https://app.cochat.ai/papers/10.1016/s2213-8587(16)30057-2
The paper
Brownrigg, J. R. W., Hughes, C. O., Burleigh, D., Karthikesalingam, A., Patterson, B. O., Holt, P. J., Thompson, M. M., de Lusignan, S., Ray, K. K., & Hinchliffe, R. J. (2016). Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(16)30057-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.